Niacin requirements for genomic stability

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 733, Issue 1-2, 2012, Pages 14-20

  Kirkland, James B ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Chromosome breaks; DNA repair; Niacin; Nicotinamide adenine dinucleotide; Poly(ADP ribose); Poly(ADP ribose) polymerase; Single and double strand breaks

Indexed keywords

MYRISTYL NICOTINATE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 3; NICOTINIC ACID; NICOTINIC ACID DERIVATIVE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); UNCLASSIFIED DRUG;

ACNE VULGARIS; ADENOSINE DIPHOSPHATE RIBOSYLATION; BONE MARROW SUPPRESSION; CALCIUM SIGNALING; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RISK; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; DIETARY REFERENCE INTAKE; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG MEGADOSE; DYSLIPIDEMIA; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; ESOPHAGUS CANCER; GENOMIC INSTABILITY; HUMAN; LEUKEMIA; LIVER METABOLISM; LUNG FUNCTION; MALNUTRITION; NICOTINIC ACID DEFICIENCY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PELLAGRA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RIBOFLAVIN DEFICIENCY; ROSACEA; SEQUENCE HOMOLOGY; SKIN CANCER; SKIN DISEASE; VITAMIN INTAKE;

ANIMALS; DIETARY SUPPLEMENTS; DNA DAMAGE; DNA REPAIR; GENOMIC INSTABILITY; HUMANS; MODELS, ANIMAL; NEOPLASMS; NIACIN; SKIN;

ANIMALIA; RATTUS;

EID: 84860584591     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.11.008     Document Type: Review

References (70)

1. Kirkland J.B. Niacin. Handbook of Vitamins 2007, 191-232. Taylor and Francis, New York. fourth ed. R. Rucker, J. Zempleni, J.W. Suttie, D.B. McCormick (Eds.).
2. Chambon P., Weill J.D., Doly J., Strosser M.T., Mandel P. On the formation of a novel adenylic compound by enzymatic extracts of liver nuclei. Biochem. Biophys. Res. Commun. 1966, 25:638-643.
3. W.T. Penberthy, Table of NAD(P)-Utilizing Enzymes, 2011. Ref type: Internet communication.
4. Penberthy W.T., Kirkland J.B. Chapter 19: Niacin. Present Knowledge in Nutrition 2011, International Life Sciences Institute-Nutrition Foundation, Washington, DC. J. Erdman, I. Macdonald, S. Ziesel (Eds.).
5. Manthey K.C., Rodriguez-Melendez R., Hoi J.T., Zempleni J. Riboflavin deficiency causes protein and DNA damage in HepG2 cells, triggering arrest in G1 phase of the cell cycle. J. Nutr. Biochem. 2006, 17:250-256.
6. Tang K., Sham H., Hui E., Kirkland J.B. Niacin deficiency causes oxidative stress in rat bone marrow cells but not through decreased NADPH or glutathione status. J. Nutr. Biochem. 2008, 19:746-753.
7. Benavente C.A., Jacobson E.L. Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytes. Free Radic. Biol. Med. 2008, 44:527-537.
8. Fu C.S., Swendseid M.E., Jacob R.A., McKee R.W. Biochemical markers for assessment of niacin status in young men: levels of erythrocyte niacin coenzymes and plasma tryptophan. J. Nutr. 1989, 119:1949-1955.
9. Tang K., Sham H., Hui E., Kirkland J.B. Niacin deficiency causes oxidative stress in rat bone marrow cells, but not through decreased NADPH or glutathione status, J. Nutr. Biochem. 2008, 19:746-753.
10. Jacobson E.L., Nunbhakdi-Craig V., Smith D.G., Chen H.Y., Wasson B.L., Jacobson M.K. ADP-ribose polymer metabolism: implications for human nutrition. ADP-Ribosylation Reactions 1992, 153-162. Springer-Verlag, New York. G.G. Poirier, P. Moreau (Eds.).
11. Rawling J.M., Jackson T.M., Roebuck B.D., Poirier G.G., Kirkland J.B. The effect of niacin deficiency on diethylnitrosamine-induced hepatic poly(ADP-ribose) levels and altered hepatic foci in the Fischer-344 rat. Nutr. Cancer 1995, 24:111-119.
12. Jackson T.M., Rawling J.M., Roebuck B.D., Kirkland J.B. Large supplements of nicotinic acid and nicotinamide increase tissue NAD+ and poly(ADP-ribose) levels but do not affect diethylnitrosamine-induced altered hepatic foci in Fischer-344 rats. J. Nutr. 1995, 125:1455-1461.
13. Rawling J.M., ApSimon M.M., Kirkland J.B. Lung poly(ADP-ribose) and NAD+ concentrations during hyperoxia and niacin deficiency in the Fischer-344 rat. Free Radic. Biol. Med. 1996, 20:865-871.
14. Boyonoski A.C., Spronck J.C., Gallacher L.M., Jacobs R.M., Shah G.M., Poirier G.G., Kirkland J.B. Niacin deficiency decreases bone marrow poly(ADP-ribose) and the latency of ethylnitrosourea-induced carcinogenesis in rats. J. Nutr. 2002, 132:108-114.
15. Boyonoski A.C., Spronck J.C., Jacobs R.M., Shah G.M., Poirier G.G., Kirkland J.B. Pharmacological intakes of niacin increase bone marrow poly(ADP-ribose) and the latency of ethylnitrosourea-induced carcinogenesis in rats. J. Nutr. 2002, 132:115-120.
16. Young G.S., Kirkland J.B. The role of dietary niacin intake and the adenosine-5'-diphosphate-ribosyl cyclase enzyme CD38 in spatial learning ability: is cyclic adenosine diphosphate ribose the link between diet and behaviour?. Nutr. Res. Rev. 2008, 21:42-55.
17. D'Amours D., Desnoyers S., D'Silva I., Poirier G.G. Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions. Biochem. J. 1999, 342(Pt. 2):249-268.
18. Huang D., Wang Y., Yang C., Liao Y., Huang K. Angiotensin II promotes poly(ADP-ribosyl)ation of c-Jun/c-Fos in cardiac fibroblasts. J. Mol. Cell. Cardiol. 2009, 46:25-32.
19. Malanga M., Althaus F.R. The role of poly(ADP-ribose) in the DNA damage signaling network. Biochem. Cell Biol. 2005, 83:354-364.
20. Wang Y.F., Kim N.S., Haince J.F., Kang H.C., David K.K., Andrabi S.A., Poirier G.G., Dawson V.L., Dawson T.M. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Sci. Signal. 2011, 4.
21. Ame J.C., Spenlehauer C., de Murcia G. The PARP superfamily. Bioessays 2004, 26:882-893.
22. Huber A., Bai P., de Murcia J.M., de Murcia G. PARP-1, PARP-2 and ATM in the DNA damage response: functional synergy in mouse development. DNA Repair (Amst.) 2004, 3:1103-1108.
23. Isabelle M., Moreel X., Gagne J.P., Rouleau M., Ethier C., Gagne P., Hendzel M.J., Poirier G.G. Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry. Proteome Sci. 2010, 8.
24. Rulten S.L., Fisher A.E.O., Robert I., Zuma M.C., Rouleau M., Ju L.M., Poirier G., Reina-San-Martin B., Caldecott K.W. PARP-3 and APLF function together to accelerate nonhomologous end-joining. Mol. Cell 2011, 41:33-45.
25. Boehler C., Gauthier L.R., Mortusewicz O., Biard D.S., Saliou J.M., Bresson A., Sanglier-Cianferani S., Smith S., Schreiber V., Boussin F., Dantzer F. Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:2783-2788.
26. Chiang Y.J., Hsiao S.J., Yver D., Cushman S.W., Tessarollo L., Smith S., Hodes R.J. Tankyrase 1 and tankyrase 2 are essential but redundant for mouse embryonic development. PLoS One 2008, 3:e2639.
27. Chang P., Coughlin M., Mitchison T.J. Interaction between poly(ADP-ribose) and NuMA contributes to mitotic spindle pole assembly. Mol. Biol. Cell 2009, 20:4575-4585.
28. Di Girolamo M., Dani N., Stilla A., Corda D. Physiological relevance of the endogenous mono(ADP-ribosyl)ation of cellular proteins. FEBS J. 2005, 272:4565-4575.
29. Koch-Nolte F., Haag F., Guse A.H., Lund F., Ziegler M. Emerging roles of NAD(+) and its metabolites in cell signaling. Sci. Signal. 2009, 2.
30. Imai S., Guarente L. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol. Sci. 2010, 31:212-220.
31. Fernandez A.F., Fraga M.F. The effects of the dietary polyphenol resveratrol on human healthy aging and lifespan. Epigenetics 2011, 6:870-874.
32. Ueda K., Kawaichi M., Hayshi O. Poly(ADP-ribose) synthetase. ADP-ribosylation Reactions, Biology and Medicine 1982, 118-155. Academic Press, New York. O. Hayashi, K. Ueda (Eds.).
33. Rawling J.M., Jackson T.M., Driscoll E.R., Kirkland J.B. Dietary niacin deficiency lowers tissue poly(ADP-ribose) and NAD+ concentrations in Fischer-344 rats. J. Nutr. 1994, 124:1597-1603.
34. Wang Q.J., Giri S.N., Hyde D.M., Nakashima J.M., Javadi I. Niacin attenuates bleomycin-induced lung fibrosis in the hamster. J. Biochem. Toxicol. 1990, 5:13-22.
35. Inculet R.I., Norton J.A., Nichoalds G.E., Maher M.M., White D.E., Brennan M.F. Water-soluble vitamins in cancer patients on parenteral nutrition: a prospective study. J. Parenter. Enteral Nutr. 1987, 11:243-249.
36. Dreizen S., McCredie K.B., Keating M.J., Andersson B.S. Nutritional deficiencies in patients receiving cancer chemotherapy. Postgrad. Med. 1990, 87(163-7):170.
37. Boyonoski A.C., Gallacher L.M., ApSimon M.M., Jacobs R.M., Shah G.M., Poirier G.G., Kirkland J.B. Niacin deficiency in rats increases the severity of ethylnitrosourea-induced anemia and leukopenia. J. Nutr. 2000, 130:1102-1107.
38. Bartleman A.P., Jacobs R., Kirkland J.B. Niacin supplementation decreases the incidence of alkylation-induced nonlymphocytic leukemia in Long-Evans rats. Nutr. Cancer 2008, 60:251-258.
39. Kostecki L.M., Thomas M., Linford G., Lizotte M., Toxopeus L., Bartleman A.P., Kirkland J.B. Niacin deficiency delays DNA excision repair and increases spontaneous and nitrosourea-induced chromosomal instability in rat bone marrow. Mutat. Res. 2007, 625:50-61.
40. Spronck J.C., Kirkland J.B. Niacin deficiency increases spontaneous and etoposide-induced chromosomal instability in rat bone marrow cells in vivo. Mutat. Res. 2002, 508:83-97.
41. Spronck J.C., Nickerson J.L., Kirkland J.B. Niacin deficiency alters p53 expression and impairs etoposide-induced cell cycle arrest and apoptosis in rat bone marrow cells. Nutr. Cancer 2007, 57:88-99.
42. Poston H.A., Wolfe M.J. Niacin requirement for optimum growth, feed conversion and protection of rainbow trout, Salmo gairdneri, from ultraviolet-B radiation. J. Fish Dis. 1985, 8:451-460.
43. Shah G.M., Le Rhun Y., Sutarjono I., Kirkland J.B. Niacin deficient SKH-1 mice are more susceptible to ultraviolet B radiation-induced skin carcinogenesis. J. Nutr. 2001, 131(11S):3150S.
44. Lejnine S., Makarov V.L., Langmore J.P. Conserved nucleoprotein structure at the ends of vertebrate and invertebrate chromosomes. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:2393-2397.
45. Cockayne D.A., Muchamuel T., Grimaldi J.C., Muller-Steffner H., Randall T.D., Lund F.E., Murray R., Schuber F., Howard M.C. Mice deficient for the ecto-nicotinamide adenine dinucleotide glycohydrolase CD38 exhibit altered humoral immune responses. Blood 1998, 92:1324-1333.
46. Yourick J.J., Dawson J.S., Benton C.D., Craig M.E., Mitcheltree L.W. Pathogenesis of 2,2'-dichlorodiethyl sulfide in hairless guinea pigs. Toxicology 1993, 84:185-197.
47. Seal A.J., Creeke P.I., Dibari F., Cheung E., Kyroussis E., Semedo P., van den Briel T. Low and deficient niacin status and pellagra are endemic in postwar Angola. Am. J. Clin. Nutr. 2007, 85:218-224.
48. Li D., Sun W.P., Zhou Y.M., Liu Q.G., Zhou S.S., Luo N., Bian F.N., Zhao Z.G., Guo M. Chronic niacin overload may be involved in the increased prevalence of obesity in US children. World J. Gastroenterol. 2010, 16:2378-2387.
49. A.R.S.U.S. Department of Agriculture, Nutrient Intakes from Food and Dietary Supplements: Mean Amounts Consumed per Individual, by Gender and Age, NHANES 2007-2008, USDA: What We Eat in America, 2010, Ref type: electronic citation.
50. Jacobson E.L. Niacin deficiency and cancer in women. J. Am. Coll. Nutr. 1993, 12:412-416.
51. Paulionis L., Kane S.L., Meckling K.A. Vitamin status and cognitive function in a long-term care population. BMC Geriatr. 2005, 5:16.
52. Serdaru M., Hausser-Hauw C., Laplane D., Buge A., Castaigne P., Goulon M., Lhermitte F., Hauw J.J. The clinical spectrum of alcoholic pellagra encephalopathy. A retrospective analysis of 22 cases studied pathologically. Brain 1988, 111(Pt. 4):829-842.
53. Monteiro J.P., da Cunha D.F., Filho D.C., Silva-Vergara M.L., dos Santos V.M., da Costa J.C., Etchebehere R.M., Gonçalves J., de Carvalho da Cunha S.F., Jordão A.A., Chiarello P.G., Vannucchi H. Niacin metabolite excretion in alcoholic pellagra and AIDS patients with and without diarrhea. Nutrition 2004, 20:778-782.
54. Prousky J.E. Pellagra may be a rare secondary complication of anorexia nervosa: a systematic review of the literature. Altern. Med. Rev. 2003, 8:180-185.
55. Shah G.M., Shah R.G., Veillette H., Kirkland J.B., Pasieka J.L., Warner R.R. Biochemical assessment of niacin deficiency among carcinoid cancer patients. Am. J. Gastroenterol. 2005, 100:2307-2314.
56. Van Rensburg S.J., Bradshaw E.S., Bradshaw D., Rose E.F. Oesophageal cancer in Zulu men, South Africa: a case-control study. Br. J. Cancer 1985, 51:399-405.
57. Wahrendorf J., Chang-Claude J., Liang Q.S., Rei Y.G., Munoz N., Crespi M., Raedsch R., Thurnham D., Correa P. Precursor lesions of oesophageal cancer in young people in a high-risk population in China (see comments). Lancet 1989, 2:1239-1241.
58. Franceschi S., Bidoli E., Baron A.E., Vecchia C.La Maize and risk of cancers of the oral cavity, pharynx, and esophagus in northeastern Italy. J. Natl. Cancer Inst. 1990, 82:1407-1411.
59. Wang H., Wei H., Ma J., Luo X. The fumonisin B1 content in corn from North China, a high-risk area of esophageal cancer. J. Environ. Pathol. Toxicol. Oncol. 2000, 19:139-141.
60. Marshall J.R., Graham S., Haughey B.P., Shedd D., O'Shea R., Brasure J., Wilkinson G.S., West D. Smoking, alcohol, dentition and diet in the epidemiology of oral cancer. Eur. J. Cancer B: Oral Oncol. 1992, 28B:9-15.
61. Fenech M., Baghurst P., Luderer W., Turner J., Record S., Ceppi M., Bonassi S. Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability - results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis 2005, 26:991-999.
62. Yong L.C., Petersen M.R. High dietary niacin intake is associated with decreased chromosome translocation frequency in airline pilots. Br. J. Nutr. 2011, 105:496-505.
63. Canner P.L., Berge K.G., Wenger N.K., Stamler J., Friedman L., Prineas R.J., Friedewald W. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J. Am. Coll. Cardiol. 1986, 8:1245-1255.
64. Bialy T.L., Rothe M.J., Grant-Kels J.M. Dietary factors in the prevention and treatment of nonmelanoma skin cancer and melanoma. Dermatol. Surg. 2002, 28:1143-1152.
65. Kirkland J.B., Millman C.G., Prousky J. Pharmacolgical use of niacin. J. Evid. Based Complement. Med. 2011, 16:91-101.
66. Shalita A.R., Smith J.G., Parish L.C., Sofman M.S., Chalker D.K. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int. J. Dermatol. 1995, 34:434-437.
67. Niren N.M. Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review. Cutis 2006, 77:11-16.
68. Jacobson E.L., Kim H., Kim M., Williams J.D., Coyle D.L., Coyle W.R., Grove G., Rizer R.L., Stratton M.S., Jacobson M.K. A topical lipophilic niacin derivative increases NAD, epidermal differentiation and barrier function in photodamaged skin. Exp. Dermatol. 2007, 16:490-499.
69. Bermudez Y., Benavente C.A., Meyer R.G., Coyle W.R., Jacobson M.K., Jacobson E.L. Nicotinic acid receptor abnormalities in human skin cancer: implications for a role in epidermal differentiation. PLoS One 2011, 6.
70. Stevens H.P., Ostlere L.S., Begent R.H., Dooley J.S., Rustin M.H. Pellagra secondary to 5-fluorouracil. Br. J. Dermatol. 1993, 128:578-580.